Holen Sie sich die Stockscreener-App
103.00
1.54%
-1.61
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$104.61
Offen:
$103.7
24-Stunden-Volumen:
819.22K
Relative Volume:
1.14
Marktkapitalisierung:
$4.55B
Einnahmen:
$3.04B
Nettoeinkommen (Verlust:
$191.94M
KGV:
24.25
EPS:
4.2479
Netto-Cashflow:
$396.44M
1W Leistung:
-8.70%
1M Leistung:
-17.51%
6M Leistung:
-9.11%
1J Leistung:
-43.24%
1-Tages-Spanne:
$102.69
$104.45
1-Wochen-Bereich:
$102.68
$112.90
52-Wochen-Spanne:
$102.58
$185.94
Teleflex Incorporated Stock (TFX) Company Profile
Firmenname
Teleflex Incorporated
Sektor
Telefon
610-225-6800
Adresse
550 E SWEDESFORD RD, WAYNE, PA
Vergleichen Sie TFX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
103.00 | 4.62B | 3.04B | 191.94M | 396.44M | 4.2479 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-02-28 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-02-27 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-07-01 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-21 | Herabstufung | Needham | Buy → Hold |
| 2023-05-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-04-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-10-26 | Eingeleitet | Mizuho | Neutral |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-29 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-09-07 | Fortgesetzt | Raymond James | Outperform |
| 2021-07-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-01-06 | Bestätigt | Needham | Buy |
| 2020-11-02 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Wells Fargo | Outperform |
| 2019-04-24 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-02-22 | Bestätigt | Needham | Strong Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-09-10 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-08-03 | Bestätigt | Needham | Buy |
| 2018-05-14 | Bestätigt | Needham | Buy |
| 2018-05-04 | Bestätigt | Needham | Buy |
| 2018-04-04 | Eingeleitet | Goldman | Neutral |
| 2017-11-10 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-11-03 | Bestätigt | Needham | Buy |
| 2017-09-08 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2017-09-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-06 | Bestätigt | Needham | Buy |
| 2017-03-07 | Eingeleitet | Needham | Buy |
| 2017-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2016-07-12 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Teleflex Incorporated Aktie (TFX) Neueste Nachrichten
Why Teleflex (TFX) Is Down 8.7% After CEO Exit, Lower 2025 Outlook And Legal Scrutiny - simplywall.st
Teleflex names new interim CEO - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Did Teleflex’s CEO Shake‑Up and Lowered 2025 Outlook Just Shift Its (TFX) Investment Narrative? - Yahoo Finance
Assessing Teleflex (TFX) Valuation After Recent Mixed Share Price Performance - Yahoo Finance
Teleflex strikes $2 billion asset sale, clears path for buybacks and focused growth - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex IncorporatedTFX - PR Newswire
Risk Off: Is Teleflex Incorporated stock technically oversoldJuly 2025 Action & Weekly Setup with ROI Potential - baoquankhu1.vn
Lobbying Update: $20,000 of TELEFLEX INCORPORATED lobbying was just disclosed - Quiver Quantitative
Global Catheters Market Size to Hit USD 55.58 Billion by 2033, Driven by Rising Cardiovascular and Urological Procedures – SNS Insider - GlobeNewswire Inc.
Teleflex Incorporated (TFX) Stock Analysis: Navigating the Medical Device Market with a 16.38% Upside Potential - DirectorsTalk Interviews
Gains Recap: What dividend safety score for Teleflex Incorporated stockTreasury Yields & Real-Time Volume Trigger Notifications - Bộ Nội Vụ
Will Teleflex Incorporated (TBH) stock sustain bullish trend into 2025Gap Up & Risk Managed Investment Signals - Улправда
Robeco Institutional Asset Management B.V. Raises Position in Teleflex Incorporated $TFX - MarketBeat
Is Teleflex Incorporated stock in buy zone after pullbackWeekly Market Outlook & Real-Time Volume Trigger Notifications - Улправда
Why retail investors favor Teleflex Incorporated stockJuly 2025 EndofMonth & Low Drawdown Investment Ideas - Улправда
Teleflex CEO leaving company - MedTech Dive
Teleflex Inc.: The Quiet Powerhouse Reinventing How Hospitals Touch the Human Body - AD HOC NEWS
Pulmonary Function Testing Market Size to Hit USD 5.66 Billion by 2033, Growing at a CAGR of 6.65% - GlobeNewswire Inc.
Could Cash Machine Teleflex Stock Be Your Next Buy? - Trefis
With Strong Cash Flow, Teleflex Stock Poised to Rise? - Trefis
Can Teleflex Stock Recover If Markets Fall? - Trefis
Teleflex Announces Leadership Transition - Sahm
Is Teleflex’s (TFX) Interim CEO Shift And Softer 2025 Guide Reframing Its Execution Story? - simplywall.st
Published on: 2026-01-09 08:22:51 - Улправда
What analyst consensus says on Teleflex Incorporated stockShare Buyback & Long-Term Safe Investment Plans - Улправда
How Teleflex Incorporated stock responds to policy changesTrade Exit Report & Technical Entry and Exit Tips - Улправда
Is Teleflex Incorporated stock a good choice for value investorsWeekly Stock Summary & Short-Term Swing Trade Alerts - ulpravda.ru
Teleflex Appoints Stuart Randle as Interim CEO - citybiz
Will Teleflex Incorporated stock outperform growth indexes2025 Historical Comparison & Community Consensus Stock Picks - ulpravda.ru
Teleflex (TFX) stock dives on CEO exit and revenue forecast cut — what investors watch next - TechStock²
Teleflex announces leadership transition as CEO Liam Kelly departs, cuts 2025 revenue guidance - MassDevice
Will Teleflex Incorporated stock benefit from Fed rate cutsDividend Hike & Free Safe Entry Trade Signal Reports - Улправда
Teleflex (NYSE:TFX) Shares Gap DownHere's Why - MarketBeat
Teleflex shares down 13.7% after lowering 2025 revenue forecast - marketscreener.com
Teleflex Has Leadership Change as CEO Liam Kelly Leaves, Lowers 2025 Revenue Guidance - Medical Product Outsourcing
Teleflex drops after lowering 2025 revenue forecast - TradingView — Track All Markets
Is Teleflex Incorporated stock attractive for ETFs2025 Pullback Review & High Yield Equity Trading Tips - Улправда
Teleflex Incorporated Provides Preliminary Earnings Guidance for the Year 2025 - marketscreener.com
Teleflex falls after lowering 2025 revenue forecast - TradingView — Track All Markets
Teleflex Incorporated Announces Management Changes - marketscreener.com
Teleflex Announces CEO Transition Amid Strategic Portfolio Shift - TipRanks
Teleflex Inc Announces CEO Transition - TradingView — Track All Markets
Teleflex Incorporated Appoints Stuart Randle as Interim President and CEO; Dr. Stephen Klasko Named Chairman of the Board - Quiver Quantitative
Will Teleflex Incorporated stock benefit from infrastructure spendingInstitutional Holding Changes & Superior Wealth Growth - ulpravda.ru
Is Teleflex Incorporated stock undervalued after correctionVWAP Trading Strategies & Free High Yield Portfolio Picks - ulpravda.ru
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates - sharewise.com
Deals tracker: UAB Health acquires Alabama medical group - Modern Healthcare
Teleflex Breaks Above 200-Day Moving AverageBullish for TFX - Nasdaq
Teleflex Incorporated (NYSE:TFX) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Finanzdaten der Teleflex Incorporated-Aktie (TFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):